ISSCR News
Major Advances and a 20 Year Celebration Ahead
Stem cell research is in a position of major transition. With an increasing number of stem cell products now reaching the market, we are on the brink of seeing stem cell-based products for a wide variety of conditions. These advances must remain founded on the highest quality fundamental stem cell research incorporating the technological advances in imaging, genomics, bioengineering, gene-editing, data science and synthetic biology.
Member Spotlight: Megan Munsie, PhD
“Get involved. No matter what aspect of stem cell research you work in, there are opportunities to participate in discussions about the ethical and societal implications of your work”.
Melissa H. Little Assumes New Role as President of the ISSCR
The ISSCR is pleased to announce Melissa H. Little, PhD, Murdoch Childrens Research Institute and University of Melbourne, Australia, as president of the ISSCR Board of Directors.
Keith Alm Assumes New Role as ISSCR CEO
The ISSCR is pleased to announce Keith Alm will today assume the role of CEO. He replaces retiring Nancy Witty, after 16 years of leadership.
Coalition Statement in Support of Research Using Human Fetal Tissue
Our organizations represent scientific, medical, and patient communities dedicated to advancing medical knowledge and improving human health. We support the continued use of human fetal tissue (HFT) in research because it is an indispensable biomedical research tool crucial for life-saving biomedical research.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .